Literature DB >> 885118

Evidence that somatomedin-C is degraded by the kidney and inhibits insulin degradation.

A J D'Ercole, C J Decedue, R W Furlanetto, L E Underwood, J J Van Wyk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 885118     DOI： 10.1210/endo-101-2-577

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  6 in total

1.  Growth factor binding and bioactivity in human kidney epithelial cell cultures.

Authors:  T Gansler; W C Hsu; T S Gramling; K A Robinson; M G Buse; N Blocker; L Roy; S Green; A J Garvin; D A Sens
Journal:  In Vitro Cell Dev Biol       Date:  1990-03

Review 2.  The renal metabolism of insulin.

Authors:  R Rabkin; M P Ryan; W C Duckworth
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

3.  Study of bioassayable somatomedin on renal artery and vein.

Authors:  F Minuto; A Barreca; P Grimaldi; R Cocco; G Garibotto; S Ferrini; G Giordano
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

4.  Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats.

Authors:  A Flyvbjerg; O Thorlacius-Ussing; R Naeraa; J Ingerslev; H Orskov
Journal:  Diabetologia       Date:  1988-05       Impact factor: 10.122

5.  Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects.

Authors:  H P Guler; C Schmid; J Zapf; E R Froesch
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  Serum insulin-like growth factor-I in diabetic retinopathy.

Authors:  John F Payne; Vin Tangpricha; Julia Cleveland; Michael J Lynn; Robin Ray; Sunil K Srivastava
Journal:  Mol Vis       Date:  2011-08-27       Impact factor: 2.367
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.